• Affordable Educational Credits
  • Watch At Your Convenience
  • Worldwide Speakers
  • Captivating Topics
  • Peer Interactions

GOLD Learning Speakers


Fedro Alessandro Peccatori, MD PhD

  • Speaker Type: GOLD Obstetrics 2020
  • Country: Italy

Fedro Peccatori is a medical and gynecologic oncologist whose clinical activities mainly include diagnosis and treatment of breast cancer, gynecological malignancies and tumors of young adults. He is Director of the Fertility and Procreation Unit within the Division of Gynecologic Oncology at the European Institute of Oncology, Milan, Italy.

His main research projects deal with fertility preservation and counselling in young oncological patients, pharmacological protection of ovarian function during chemotherapy, clinical and molecular characterization of pregnancy associated cancers and research protocols for the treatment of breast and gynaecological malignancies during pregnancy.

He has acted as lecturer in a number of international meetings, and holds a teaching contract with the University of Milan. He has received research grants from the Italian Ministry of Health and has acted as referee for a number of international journals, being part of the Editorial Board of Tumori Journal and Journal of Human Lactation. He’s member of the European Society of Medical Oncology task force Adolescent and Young Adult and faculty member for breast cancer. At present, he acts as Scientific Director at the European School of Oncology, where he’s in charge of organizing and supervising international courses and masterclasses on different oncological issues.

CE Library Presentation(s) Available Online:
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Management Of Breast Cancer During Pregnancy
Breast cancer is the most common cancer diagnosed during pregnancy. The incidence of breast cancer in pregnancy is expected to rise since women tend to postpone childbearing and the incidence of breast cancer increases with age. The management of this situation is a clinical challenge for all the involved health care providers and relies on multidisciplinarity and shared decision making with the patient and her partner. Diagnostic imaging and staging may be safely performed during pregnancy, favoring methods without ionizing radiations (e.g. ultrasound and MRI). Surgery is possible throughout the whole pregnancy. Chemotherapy can be safely administered to the mother starting from the second trimester, without fetal impairment. Data about the impact of chemotherapy on subsequent child development are reassuring, but long term follow-up is needed. In this lecture we will present an overview of the current knowledge about the biology, prognosis and treatment options of breast cancer during pregnancy, highlighting results of recent research on neonatal outcome and recommendations concerning prenatal care!
Accreditation, Live Webinar
Presentations: 12  |  Hours / CE Credits: 10.5  |  Viewing Time: 8 Weeks
Hours / CE Credits: (details)  |  Categories: